OSMOTICA PHARMACEUTICALS PLC's ticker is OSMT and the CUSIP is G6S41R101. A total of 63 filers reported holding OSMOTICA PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 2 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | -87.5% | 2 | -71.4% | 0.00% | – |
| Q1 2023 | $8 | 0.0% | 7 | 0.0% | 0.00% | – |
| Q4 2022 | $8 | -99.9% | 7 | 0.0% | 0.00% | – |
| Q3 2022 | $15,000 | +50.0% | 7 | 0.0% | 0.00% | – |
| Q2 2022 | $10,000 | -94.5% | 7 | -93.5% | 0.00% | – |
| Q1 2022 | $181,000 | +42.5% | 107 | +148.8% | 0.00% | – |
| Q3 2021 | $127,000 | -99.0% | 43 | -99.0% | 0.00% | – |
| Q2 2021 | $13,084,000 | -17.6% | 4,347 | -10.8% | 0.00% | – |
| Q1 2021 | $15,886,000 | +3.1% | 4,873 | +30.3% | 0.00% | – |
| Q4 2020 | $15,413,000 | +18.7% | 3,741 | +55.9% | 0.00% | – |
| Q3 2020 | $12,984,000 | +367.2% | 2,400 | +481.1% | 0.00% | – |
| Q2 2020 | $2,779,000 | -67.2% | 413 | -84.5% | 0.00% | – |
| Q1 2020 | $8,475,000 | +16.7% | 2,665 | +156.5% | 0.00% | – |
| Q4 2019 | $7,263,000 | +4.5% | 1,039 | -42.6% | 0.00% | – |
| Q3 2019 | $6,950,000 | +1.4% | 1,810 | +0.3% | 0.00% | – |
| Q2 2019 | $6,855,000 | – | 1,804 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 8,148,832 | $11,082,000 | 4.66% |
| Rovida Advisors Inc. | 3,000,000 | $4,020,000 | 1.03% |
| Marietta Wealth Management, LLC | 120,000 | $163,000 | 0.04% |
| TITLEIST CAPITAL, LLC | 118,303 | $161,000 | 0.04% |
| AIGH Capital Management LLC | 84,993 | $116,000 | 0.03% |
| ArrowMark Colorado Holdings LLC | 1,623,000 | $2,207,000 | 0.02% |
| Insight Advisors, LLC/ PA | 37,823 | $59,000 | 0.02% |
| Tower View Wealth Management LLC | 4,100 | $6,000 | 0.00% |
| SFMG, LLC | 10,000 | $14,000 | 0.00% |
| Atria Wealth Solutions, Inc. | 27,000 | $37,000 | 0.00% |